Treatment Options for Eczema
A stepwise approach beginning with topical therapies is the recommended first-line treatment for most patients with eczema, with phototherapy and systemic therapies reserved for more severe or refractory cases. 1
First-Line Treatments: Topical Therapies
Topical Corticosteroids
- Potent and moderate topical corticosteroids are more effective than mild corticosteroids for treating eczema, particularly for moderate to severe cases 2, 3
- Apply twice daily for up to 4 weeks initially for flares 1
- Once-daily application of potent topical corticosteroids is as effective as twice-daily application 2, 4
- Potency selection guidelines:
- Mild (Class 5-7): Face, genitals, skin folds, infants
- Moderate (Class 3-4): Trunk, extremities, children
- Potent/Very potent (Class 1-2): Reserved for thick, lichenified, or treatment-resistant lesions 1
- Weekend therapy (proactive approach) applying topical corticosteroids twice weekly can prevent flares after improvement 1, 2
- Monitor for adverse effects including skin atrophy, striae, telangiectasia, and purpura 1
Topical Calcineurin Inhibitors
- Strongly recommended for mild to moderate eczema, particularly for sensitive areas 1
- No risk of skin atrophy, making them suitable for long-term use 1
- Examples include:
- Pimecrolimus should not be used:
- Continuously for long periods
- In children under 2 years old
- In patients with weakened immune systems 6
- Most common side effects include burning or warmth sensation at application site 6, 5
Topical PDE-4 Inhibitors
- Crisaborole 2% is strongly recommended for mild to moderate eczema 1
- May cause application site reactions more commonly than topical steroids 3
Topical JAK Inhibitors
- Strongly recommended for mild to moderate eczema 1
- Ruxolitinib 1.5%, delgocitinib 0.5% or 0.25% ranked among most effective topical treatments 3
Second-Line Treatment: Phototherapy
- Conditionally recommended for moderate to severe eczema when topical therapies are insufficient 1
- Narrowband UVB is generally preferred for adolescents, under specialist supervision 1
- Safe and effective for moderate to severe atopic dermatitis when first-line treatments are inadequate 7
Third-Line Treatments: Systemic Therapies
Biologics
- Strongly recommended for severe, widespread, or refractory eczema 1
- Examples include dupilumab and tralokinumab 1, 7
Oral JAK Inhibitors
- Strongly recommended for severe, widespread, or refractory eczema 1
- Examples include abrocitinib, baricitinib, and upadacitinib 1
Immunomodulators
- Conditionally recommended for severe, widespread, or refractory eczema 1
- Examples include cyclosporine, methotrexate, azathioprine, and mycophenolate 1
Systemic Corticosteroids
- Conditionally recommended against due to rebound flares upon discontinuation and adverse effects with long-term use 1
- May be considered as short-term intervention (<7 days) for severe acute exacerbations when other options have failed 1
Skin Care and Prevention
- Apply fragrance-free emollients 3-8 times daily, even when skin appears normal 1
- Preferably apply emollients immediately after bathing to lock in moisture 1
- Use gentle, pH-neutral synthetic detergents instead of soap 1
- Avoid irritants such as perfumes, deodorants, and alcohol-based lotions 1
- Identify and eliminate triggering substances 1
- Consider air purifiers to reduce PM 2.5 exposure, especially during dry moderate weather conditions 1
Infection Prevention and Treatment
- Treat clinically evident infections with appropriate antibiotics 1
- Consider antiseptic washes with aqueous chlorhexidine 0.05% for erosive lesions 1
- Bleach baths with 0.005% sodium hypochlorite twice weekly can help prevent infections 1
- Evidence does not support routine use of oral or topical antistaphylococcal treatments for infected eczema 4
Important Considerations and Pitfalls
Avoid under-treatment: More aggressive use of topical therapies using the "get control then keep control" regimen is recommended 4
Avoid unnecessary treatments:
Safety monitoring:
When to refer to specialists:
- Diagnostic doubt
- Failure to respond to maintenance treatment with appropriate topical steroids
- When second-line treatment is required 1